Observation of a cohort of 400 patients with different types of lymphomas.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall survival rate among patients with Hodgkin Lymphomas
Timeframe: 2 years after inclusion
Overall survival rate among patients with Mantle-cell Lymphomas
Timeframe: 2 years after inclusion
Overall survival rate among patients with Primitive Cerebral Lymphomas
Timeframe: 2 years after inclusion
Overall survival rate among patients with Follicular Lymphomas
Timeframe: 2 years after inclusion
Overall survival rate among patients with Marginal Zone Lymphomas
Timeframe: 2 years after inclusion
Overall survival rate among patients with Waldenström's Disease
Timeframe: 2 years after inclusion